These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 27317305)

  • 1. Pharmacokinetic Properties of Peramivir After Single and Multiple Intravenous Infusions in Healthy Chinese Volunteers.
    Zhang M; Wang ZZ; Ni XJ; Li LZ; Zhang YF; Lu HY; Peng H; Huang WC; Shen LF; Xiong LH; Shang DW; Wen YG
    Clin Drug Investig; 2016 Sep; 36(9):705-711. PubMed ID: 27317305
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of peramivir after single intravenous doses in healthy Chinese subjects.
    Zhang D; Du A; Zhang L; Ma J; Meng L; Deng M; Xu J; Liu H
    Xenobiotica; 2015 Mar; 45(3):239-43. PubMed ID: 25231091
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics and safety of intravenous peramivir, neuraminidase inhibitor of influenza virus, in healthy Japanese subjects.
    Saisho Y; Ishibashi T; Fukuyama H; Fukase H; Shimada J
    Antivir Ther; 2017; 22(4):313-323. PubMed ID: 27805571
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Absence of pharmacokinetic interaction between intravenous peramivir and oral oseltamivir or rimantadine in humans.
    Atiee G; Lasseter K; Baughman S; McCullough A; Collis P; Hollister A; Hernandez J
    J Clin Pharmacol; 2012 Sep; 52(9):1410-9. PubMed ID: 21960669
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of intravenous peramivir in the airway epithelial lining fluid of healthy volunteers.
    Funatsu Y; Tasaka S; Asami T; Namkoong H; Fujiwara H; Iketani O; Yagi K; Kimizuka Y; Ishii M; Nishimura T; Ogata H; Iwata S; Betsuyaku T; Hasegawa N
    Antivir Ther; 2016; 21(7):621-625. PubMed ID: 27694694
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics and Tolerability of Rufinamide Following Single and Multiple Oral Doses and Effect of Food on Pharmacokinetics in Healthy Chinese Subjects.
    Xu M; Ni Y; Zhou Y; He X; Li H; Chen H; Li W
    Eur J Drug Metab Pharmacokinet; 2016 Oct; 41(5):541-8. PubMed ID: 26294172
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influenza viral load and peramivir kinetics after single administration and proposal of regimens for peramivir administration against resistant variants.
    Sato M; Ito M; Suzuki S; Sakuma H; Takeyama A; Oda S; Watanabe M; Hashimoto K; Miyazaki K; Kawasaki Y; Hosoya M
    Antimicrob Agents Chemother; 2015 Mar; 59(3):1643-9. PubMed ID: 25547357
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peramivir pharmacokinetics in a patient receiving continuous veno-venous hemodiafiltration during the 2009 H1N1 influenza A pandemic.
    Bentley ML; Hollistera AS; Hansenb AC; Smith JA; Cain JS
    Int J Clin Pharmacol Ther; 2014 Dec; 52(12):1105-11. PubMed ID: 25345428
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peramivir: A Review in Uncomplicated Influenza.
    Scott LJ
    Drugs; 2018 Sep; 78(13):1363-1370. PubMed ID: 30196350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The relationship between in vivo antiviral activity and pharmacokinetic parameters of peramivir in influenza virus infection model in mice.
    Kodama M; Yoshida R; Hasegawa T; Izawa M; Kitano M; Baba K; Noshi T; Seki T; Okazaki K; Tsuji M; Kanazu T; Kamimori H; Homma T; Kobayashi M; Sakoda Y; Kida H; Sato A; Yamano Y
    Antiviral Res; 2014 Sep; 109():110-5. PubMed ID: 24997412
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tolerability and pharmacokinetics of ranolazine following single and multiple sustained-release doses in Chinese healthy adult volunteers: a randomized, open-label, Latin square design, phase I study.
    Tan QY; Li HD; Zhu RH; Zhang QZ; Zhang J; Peng WX
    Am J Cardiovasc Drugs; 2013 Feb; 13(1):17-25. PubMed ID: 23355361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of cefozopran by single and multiple intravenous infusions in healthy Chinese volunteers.
    Wu GL; Shentu JZ; Zhou HL; Zhu MX; Hu XJ; Liu J; Wu LH
    Drugs R D; 2015 Mar; 15(1):63-70. PubMed ID: 25644122
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peramivir pharmacokinetics in two critically ill adults with 2009 H1N1 influenza A concurrently receiving continuous renal replacement therapy.
    Bazan JA; Bauer KA; Hollister AS; Shidham G; Firstenberg MS; Reed EE; Mangino JE; Goff DA
    Pharmacotherapy; 2010 Oct; 30(10):1016-20. PubMed ID: 20874039
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy, safety, and pharmacokinetics of intravenous peramivir in children with 2009 pandemic H1N1 influenza A virus infection.
    Sugaya N; Kohno S; Ishibashi T; Wajima T; Takahashi T
    Antimicrob Agents Chemother; 2012 Jan; 56(1):369-77. PubMed ID: 22024821
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics and Tolerability of Single and Multiple Intravenous Doses of Cefotetan Disodium in Healthy Chinese Volunteers.
    Liu J; Zhai Y; Wu L; Wu G; Zheng Y; Hu X; Shentu J
    Drug Des Devel Ther; 2020; 14():613-620. PubMed ID: 32103903
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of intravenous peramivir for treatment of seasonal influenza virus infection.
    Kohno S; Kida H; Mizuguchi M; Shimada J;
    Antimicrob Agents Chemother; 2010 Nov; 54(11):4568-74. PubMed ID: 20713668
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peramivir for Influenza A and B Viral Infections: A Pharmacokinetic Case Series.
    Cies JJ; Moore WS; Enache A; Chopra A
    Pharmacotherapy; 2019 Nov; 39(11):1060-1065. PubMed ID: 31514223
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetic properties of S-adenosylmethionine after oral and intravenous administration of its tosylate disulfate salt: a multiple-dose, open-label, parallel-group study in healthy Chinese volunteers.
    Yang J; He Y; Du YX; Tang LL; Wang GJ; Fawcett JP
    Clin Ther; 2009 Feb; 31(2):311-20. PubMed ID: 19302903
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical experience in adults and children treated with intravenous peramivir for 2009 influenza A (H1N1) under an Emergency IND program in the United States.
    Hernandez JE; Adiga R; Armstrong R; Bazan J; Bonilla H; Bradley J; Dretler R; Ison MG; Mangino JE; Maroushek S; Shetty AK; Wald A; Ziebold C; Elder J; Hollister AS; Sheridan W;
    Clin Infect Dis; 2011 Mar; 52(6):695-706. PubMed ID: 21367722
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantification of peramivir (a novel anti-influenza drug) in human plasma by hydrophilic interaction chromatography/tandem mass spectrometry.
    Li Y; Zhang X; Wang X; Li S; Ruan J; Zhang Z
    J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Apr; 877(10):933-8. PubMed ID: 19285926
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.